COMMUNITY AND COHORT SURVEILLANCE PROGRAM

社区和群体监测计划

基本信息

项目摘要

ARIC is a large-scale, long-term program that will measure associations of established and suspected coronary heart disease risk factors (CHD) with both atherosclerosis and new CHD events such as myocardial infarction in men and women from four diverse communities. The project has two components: community surveillance of morbidity and mortality, and repeated examinations of a representative cohort of men and women in each community. The community surveillance involves abstracting hospital records and death certificates and investigating out-of- hospital deaths. The representative cohorts include 4,000 persons from each community. Three of these reflect the ethnic composition of the communities in which they live; one cohort is black. All cohort participants are examined four times (1987-90), and 1990-93, 1993-96, and 1996-99), and contacted annually to update their medical histories. Atherosclerosis is measured by carotid and ultrasonography. Arteriosclerosis is measured using retinal photography. Cerebrovascular disease is assessed using MRI in a sample of black and white participants. Rick factors studied include: blood lipids, lipoprotein cholesterols, and apolipoproteins; plasma hemostatic factors; diabetes and glucose intolerance; blood chemistries and hematology and indicators and infectious and inflammatory disease; DNA markers of these risk factors; sitting, supine and standing blood pressures to track the development of hypertension; anthropometry; fasting blood glucose and insulin level as predictors of diabetes; ECG findings; heart rate variability; cigarette and alcohol use; physical activity level; dietary aspects; and family history. The diverse communities can be compared with respect to CHD incidence and medical care and, through the cohort component, with respect to risk factors and peripheral atherosclerosis. The results will provide a measure of the variation in the distribution and determinants of CHD in the U.S. and, within the limits of ecologic analysis, suggest possible reasons for observed differences. The contractor serves as the Central Lipid Laboratory for the ARIC. Duties include performing lipid measurements, including total cholesterol, high density lipoprotein cholesterol, triglycerides, and glucose on samples from all participants under study by the Field Centers.
ARIC是一项大规模的长期计划,将衡量关联性 已确诊和疑似冠心病危险因素(CHD) 动脉粥样硬化和新的冠心病事件,如心肌梗死 来自四个不同社区的男性和女性都发生了脑梗塞。该项目 有两个组成部分:发病率和死亡率的社区监测, 以及对具有代表性的男性和女性队列的反复检查 在每个社区。社区监督包括抽象 医院记录和死亡证明以及调查期间 医院死亡。代表队列包括来自 每个社区。其中三个反映了 他们所在的社区;一个队列是黑人。 所有队列参与者都接受了四次检查(1987-90年)和1990-93年, 1993-96和1996-99),并每年联系更新他们的医疗信息 历史。动脉粥样硬化是通过颈动脉和超声检查来测量的。 动脉硬化是用视网膜照相来测量的。脑血管 在黑白样本中使用磁共振成像来评估疾病 参与者。研究的瑞克因素包括:血脂、脂蛋白 胆固醇和载脂蛋白;血浆止血因子;糖尿病 和糖耐量异常;血液化学、血液学和指标 以及传染病和炎症性疾病;这些风险的DNA标记 因素;坐位、仰位和站立的血压跟踪 高血压的发展;人体测量;空腹血糖和 胰岛素水平可作为糖尿病的预测因子;心电图表现;心率 可变性;烟酒使用;体力活动水平;饮食 方面;以及家族史。 就冠心病发病率而言,可以比较不同的社区 和医疗保健,并通过队列组成部分,在风险方面 因素与外周动脉粥样硬化。结果将提供一个 中国冠心病分布及决定因素变异的测量方法 美国和,在生态分析的范围内,建议有可能 观察到差异的原因。 该承包商是ARIC的中央脂质实验室。 职责包括进行血脂测量,包括总量 胆固醇、高密度脂蛋白胆固醇、甘油三酯和 现场研究的所有参与者的样本中的葡萄糖 中锋。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTIE Mitchell BALLANTYNE其他文献

CHRISTIE Mitchell BALLANTYNE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTIE Mitchell BALLANTYNE', 18)}}的其他基金

Clonal hematopoiesis in humans: determinants of development and progression
人类克隆造血:发育和进展的决定因素
  • 批准号:
    10202719
  • 财政年份:
    2019
  • 资助金额:
    $ 39.19万
  • 项目类别:
Clonal hematopoiesis in humans: determinants of development and progression
人类克隆造血:发育和进展的决定因素
  • 批准号:
    9980999
  • 财政年份:
    2019
  • 资助金额:
    $ 39.19万
  • 项目类别:
Clonal hematopoiesis in humans: determinants of development and progression
人类克隆造血:发育和进展的决定因素
  • 批准号:
    10448235
  • 财政年份:
    2019
  • 资助金额:
    $ 39.19万
  • 项目类别:
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease
分析老年人的心血管事件和生物标志物,以改进预防心脏和血管疾病的个性化方法
  • 批准号:
    9277554
  • 财政年份:
    2016
  • 资助金额:
    $ 39.19万
  • 项目类别:
EFFECT OF LIPID MODIFICATION ON PERIPHERAL ARTERIAL DISEASE AFTER ENDOVASCULA
脂质修饰对血管内术后周围动脉疾病的影响
  • 批准号:
    8356766
  • 财政年份:
    2010
  • 资助金额:
    $ 39.19万
  • 项目类别:
T Cells, Macrophages, Chemokines, and Adiposopathy in Diet-Induced Obesity
饮食引起的肥胖中的 T 细胞、巨噬细胞、趋化因子和脂肪病
  • 批准号:
    8452140
  • 财政年份:
    2009
  • 资助金额:
    $ 39.19万
  • 项目类别:
T Cells, Macrophages, Chemokines, and Adiposopathy in Diet-Induced Obesity
饮食引起的肥胖中的 T 细胞、巨噬细胞、趋化因子和脂肪病
  • 批准号:
    7825438
  • 财政年份:
    2009
  • 资助金额:
    $ 39.19万
  • 项目类别:
Genetics and Personalized Medicine: From Population Studies to Clinical Therapy
遗传学和个性化医疗:从人口研究到临床治疗
  • 批准号:
    7936114
  • 财政年份:
    2009
  • 资助金额:
    $ 39.19万
  • 项目类别:
T Cells, Macrophages, Chemokines, and Adiposopathy in Diet-Induced Obesity
饮食引起的肥胖中的 T 细胞、巨噬细胞、趋化因子和脂肪病
  • 批准号:
    8249901
  • 财政年份:
    2009
  • 资助金额:
    $ 39.19万
  • 项目类别:
EFFECT OF LIPID MODIFICATION ON PERIPHERAL ARTERIAL DISEASE AFTER ENDOVASCULA
脂质修饰对血管内术后周围动脉疾病的影响
  • 批准号:
    8166761
  • 财政年份:
    2009
  • 资助金额:
    $ 39.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了